Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Maxcyte (MXCT) Gross Profit (2020 - 2026)

Maxcyte has reported Gross Profit over the past 6 years, most recently at $5.7 million for Q4 2025.

  • Quarterly Gross Profit fell 11.26% to $5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.8 million through Dec 2025, down 14.98% year-over-year, with the annual reading at $26.8 million for FY2025, 14.98% down from the prior year.
  • Gross Profit was $5.7 million for Q4 2025 at Maxcyte, up from $5.2 million in the prior quarter.
  • Over five years, Gross Profit peaked at $14.1 million in Q4 2023 and troughed at $5.2 million in Q3 2025.
  • The 5-year median for Gross Profit is $8.1 million (2022), against an average of $8.2 million.
  • Year-over-year, Gross Profit surged 81.4% in 2022 and then plummeted 54.5% in 2024.
  • A 5-year view of Gross Profit shows it stood at $8.9 million in 2021, then grew by 21.86% to $10.9 million in 2022, then increased by 29.56% to $14.1 million in 2023, then plummeted by 54.5% to $6.4 million in 2024, then dropped by 11.26% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Gross Profit are $5.7 million (Q4 2025), $5.2 million (Q3 2025), and $7.0 million (Q2 2025).